Daewoong Pharmaceutical announced on the 28th that its botulinum toxin 'Nuceiva' was officially launched in Germany and Austria through Evolus, a cosmetic indication partner in developed countries. Evolus, a partner for cosmetic indications in North America and the European Union, will be in charge of the distribution and marketing of Nuciva in Germany and Austria. Evolus has been preparing for the local release by forming a strategic partnership with Novvia, a local distributor specializing in aesthetic medicine. From the middle of this month, we started product marketing activities targeting local medical personnel.

According to a data report published by market research firm Decision Resource Group (